Swiss Medtech Award
The Swiss Medtech Award is aimed at companies in the Swiss medical technology sector that have achieved outstanding entrepreneurial achievements or innovations. Companies are nominated by the nomination committee, which consists of eight individuals with extensive networks covering all regions of Switzerland. The nomination committee conducts an initial pre-selection and chooses the companies to be presented for jury appraisal.
The nominated companies must also meet formal and objective criteria to be eligible to present their achievements to the jury, chaired by Prof. Mirko Meboldt from ETH Zurich. The winning team will be announced and celebrated at Swiss Medtech Day, the most important event for the Swiss medical technology industry, and will receive a prize valued at CHF 75,000. Reserve now to attend this interesting event on 11 June 2024.
Contact
Previous Winners
Who can be nominated?
During the nomination phase, the nomination committee will make their preselection by the end of December 2023. Subsequently, the nominated companies will be contacted, and they can submit their applications online. The applications will be evaluated by the jury until mid-March 2024, followed by the selection of the top three candidates. The top three companies will have the opportunity to present their performance to the jury at the jury hearing in April 2024.
The winning team will be announced at the Swiss Medtech Day and honored with a prize money of CHF 75,000.
You can also take an active role: if you wish to submit a company or research group for consideration, please contact the project manager Angela D'Aranno by 1st February 2024.
Nomination criteria
Candidates selected by the nominating partners must meet the following criteria.
Official criteria
All three official criteria must be fully met.
- Medical Technology Sector
The companies, their products and solutions must be active in the medical technology industry. - Market success
Candidates must prove that the goods or services provided have already found success on the market. - «Swissness» factor
The achievements and provision of services must have been developed to a significant extent within Switzerland.
Factual criteria
At least one of the following factual criteria must be met.
- Proven patient benefit
A new product or product line with significant patient benefits has already been launched. - Provision of Health care
Public healthcare has been advanced through pioneering, groundbreaking, and innovative technologies or processes. - Entrepreneurial achievement
Outstanding entrepreneurial performance has been achieved in the recent past.
Nominating Partners
Peter Biedermann
Member of the nomination committee
Director
Swiss Medtech
Magali Bischof
Member of the nomination committee
Secretary General
BioAlps Association
Hans Ebinger
Member of the nomination committee
CEO
Switzerland Innovation Park Ost
Lukas Huber
Member of the nomination committee
Deputy Managing Director
Greater Zurich Area Ltd.
Christoph Lang
Member of the nomination committee
Managing Director
ITZ InnovationsTransfer Zentralschweiz
Ulrike Neuberger
Member of the nomination committee
Co-Founder & Partner
MEDICALBOARD – Expertise in Healthcare
Giuseppe Perale
Member of the nomination committee
Executive VP & Founder I.B.I. SA
Regenera SA
Katrin Siebenbürger Hacki
Member of the nomination committee
Director
Medows GmbH
Jury
Prof Dr Mirko Meboldt
President of the Jury
Chair of Product Development
& Engineering
ETH Zurich
Dr Gery Colombo
Member of the Jury
Chief Technology Officer
VAMED Schweiz
Prof Dr Emanuela Keller
Member of the Jury
Head Neurocritical Care Unit
University Hospital Zurich
Hans Ulrich Lehmann
Member of the Jury
Vice President, Product Area Head Autoinjectors
Ypsomed
Stephan Oehler
Member of the Jury
Head of Technology & Testing
Straumann
Andi Vonlanthen
Member of the Jury
Group Vice President R&D
Sonova Holding
Donors
 |
 |
 |